Molecular Triaging of Newly Diagnosed Breast Cancer

NCT01159236 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Recent developments lead to re-evaluation of study.

Conditions

Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Fluorouracil
DRUG: Doxorubicin
DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: Bevacizumab

Sponsor

M.D. Anderson Cancer Center